The agency's Digital Health Advisory Committee will meet on November 6 and focus on how these digital tools could help ...

Dr. Erik Langhoff, chief medical officer and consultant for the Bronx Regional Health Information Organization, discusses how ...

The FDA will convene experts on Nov. 6 to discuss challenges around regulating mental health products that use artificial ...

A strong pre-submission is a strategic tool. When reviewers are stretched thin, submission quality shapes the experience.

Rapid scientific advances are accelerating the development of medical innovations, from personalized treatments to curative ...

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results ...

Shares of Tempus AI surged to a seven-month high on Thursday, jumping 13.59 percent to close at $88.78 apiece as investors ...

Imagine a living systematic review in real-time, providing a comprehensive, up-to-date synthesis of the evidence—backed by AI ...

On September 9, 2025, the U.S. Food and Drug Administration (FDA) announced it is launching a targeted initiative to combat deceptive drug advertising.

The FDA will convene its Digital Health Advisory Committee Nov. 6 to discuss the use of generative artificial ...